Witness Football

UEFA bans Ajax goalkeeper Andre Onana for doping violation

Share on facebook
Share on google
Share on twitter
Share on linkedin

Ajax goalkeeper, Andre Onana, has been banned for 12 months after the player failed a doping test done in October, UEFA confirmed. The Cameroon international reportedly tested for furosemide which is a diuretic and is one of the drugs in the prohibited list released by UEFA last year.

Furosemide is a drug that is often used by athletes as a masking agent to hide the presence of other Performance- enhancing drugs (PED), this is why UEFA has decided to give the 24-year-old such a harsh sentence.

Onana who has won the best goalkeeper in Holland four times and the best African goalkeeper three times in his career till now is now likely to miss the African cup of Nations, which is scheduled to be held in his country, due to the ban.

Ajax released a statement this evening saying the goalkeeper took a pill prescribed to his wife by mistake when he was not feeling well. They have decided to further appeal the decision in the Court of Arbitration for Sports (CAS) and will be hoping to get the decision overruled.

Speaking about the UEFA verdict, Ajax managing director and ex-Manchester United legend Edwin Van Der Sar said :

“We had hoped for a conditional suspension or for a suspension much shorter than these twelve months, because it was arguably not intended to strengthen his body and thus improve his performance,”

Things have gone from bad to worse for Ajax this week:

Not only have Ajax lost Andre Onana for a year due to a doping charge, but the club also announced that they failed to register record signing Sebastian Haller who moved to the club in a reported 22 million pound deal from West Ham for the upcoming Europa league games.

Highly rated youngsters Julian Rijkhoff and Brian Brobbey from the Ajax academy have rejected contract extensions from the club and will leave the Dutch club as free agents at the end of this season.

Image Credit- Andre Onana Twitter

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on whatsapp
Akash Das

Akash Das

Leave a Reply